10 Financials Stocks Moving In Monday’s Intraday Session
Gainers Universal Insurance Hldgs (NYSE:UVE) shares moved upwards by 18.9% to $17.89 during Monday’s regular session. As of…
Top Financial Stocks That Are Preparing To Pump In February
The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
Exclusive: Former Washington D.C. Attorney General, Karl Racine, Joins Board Of A Cannabis-Friendly Bank Alternative
SHF Holdings, Inc. ( d/b/a/ Safe Harbor Financial) (NASDAQ: SHFS) confirmed Wednesday that Karl A. Racine has commenced active participation on the company’s board of directors following his January 2023 departure from office.
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday’s Mid-Day Session
Gainers
Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
PaxMedica, SurgePays, Opal Fuels And More Short Squeeze Candidates That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Getty Images, MoonLake And 3 Other Short Squeeze Candidates That May Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Safe Harbor Financial Reports Q3 Revenue Increase To $2.38M QoQ
Safe Harbor Financial (NASDAQ: SHFS), a leader in facilitating financial services to the regulated cannabis industry, announced its financial results late Monday for the third quarter that ended September 30, 2022.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.